Cryoport, Inc. — Director's Dealing 2021

Nov 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-11-10

Reporting Person: SHELTON JERRELL (Director, President, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-10	Common Stock	M	8334	$2.28	Acquired	572426	Direct
2021-11-10	Common Stock	M	56916	$2.40	Acquired	629342	Direct
2021-11-10	Common Stock	S	10619	$77.9731	Disposed	618723	Direct
2021-11-10	Common Stock	S	22554	$78.7252	Disposed	596169	Direct
2021-11-10	Common Stock	S	25167	$79.8094	Disposed	571002	Direct
2021-11-10	Common Stock	S	6910	$80.6624	Disposed	564092	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-10	Option to purchase common stock	$2.28	M	8334	Disposed	2022-10-22	Common Stock (8334)	Direct
2021-11-10	Option to purchase common stock	$2.40	M	56916	Disposed	2022-11-05	Common Stock (56916)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.32 to $78.30, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.32 to $79.29, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.32 to $80.31, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.32 to $81.15, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013.

F7: 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013.